These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 177111

  • 1. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica.
    Lotzova E, Gallagher MT, Trentin JJ.
    Biomedicine; 1975 Sep; 22(5):387-92. PubMed ID: 177111
    [Abstract] [Full Text] [Related]

  • 2. Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan.
    Cudkowicz G, Yung YP.
    J Immunol; 1977 Aug; 119(2):483-7. PubMed ID: 196023
    [No Abstract] [Full Text] [Related]

  • 3. Macrophage involvement in genetic resistance to bone marrow transplantation.
    Lotzová E, Gallagher MT, Trentin JJ.
    Transplant Proc; 1976 Sep; 8(3):477-82. PubMed ID: 185761
    [No Abstract] [Full Text] [Related]

  • 4. Abrogation of resistance to foreign bone marrow grafts by carrageenans. II. Studies with the anti-macrophage agents iota, kappa, and lambda-carrageenans.
    Yung YP, Cudkowicz G.
    J Immunol; 1977 Oct; 119(4):1310-5. PubMed ID: 330763
    [No Abstract] [Full Text] [Related]

  • 5. Abrogation of resistance to bone marrow grafts by silica particles. Prevention of the silica effect by the macrophage stabilizer poly-2-vinylpyridine N-oxide.
    Lotzová E, Cudkowicz G.
    J Immunol; 1974 Sep; 113(3):798-803. PubMed ID: 4369740
    [No Abstract] [Full Text] [Related]

  • 6. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
    Buurman WA, van Bruggen I.
    Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
    [Abstract] [Full Text] [Related]

  • 7. Possible involvement of natural killer cells in bone marrow graft rejection.
    Lotzová E, Savary CA.
    Biomedicine; 1977 Dec; 27(9-10):341-4. PubMed ID: 203349
    [Abstract] [Full Text] [Related]

  • 8. [Effect of antilymphocytic, antithymocytic and anti-macrophage sera on genetically determined resistance of irradiated mice to transplanted bone marrow].
    Zupańska B.
    Acta Haematol Pol; 1977 Dec; 8(2):161-6. PubMed ID: 329630
    [No Abstract] [Full Text] [Related]

  • 9. Influence of silica and carrageenan on spleen colonies and colonies in murine peritoneal cell-coated cellulose acetate membranes.
    Lai PK, Boggs DR, Boggs SS.
    Stem Cells (1981); 1982 Dec; 2(1):1-10. PubMed ID: 6297099
    [Abstract] [Full Text] [Related]

  • 10. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
    Gerlier D, Avice T, Doré JF.
    Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
    [Abstract] [Full Text] [Related]

  • 11. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T, Oh-hashi F, Sakurai Y, Gomi K.
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [Abstract] [Full Text] [Related]

  • 12. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E.
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract] [Full Text] [Related]

  • 13. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS, Bennett M, Kumar V.
    Nat Immun Cell Growth Regul; 1986 May; 5(4):200-10. PubMed ID: 2430178
    [Abstract] [Full Text] [Related]

  • 14. Suppression of genetic resistance to bone marrow grafts and natural killer activity by administration of fat emulsion.
    Tezuka H, Sawada H, Sakoda H, Itoh K, Nishikori M, Amagai T, Uchino H, Mori KJ.
    Exp Hematol; 1988 Aug; 16(7):609-12. PubMed ID: 3292278
    [Abstract] [Full Text] [Related]

  • 15. Genetic resistance in the graft-versus-host reaction.
    Sula K, Nouza K.
    Exp Clin Immunogenet; 1984 Aug; 1(3):175-84. PubMed ID: 6101099
    [Abstract] [Full Text] [Related]

  • 16. Resistance of irradiated F 1 hybrid and allogeneic mice to bone marrow grafts of NZB donors.
    Lotzová E, Cudkowicz G.
    J Immunol; 1973 Mar; 110(3):791-800. PubMed ID: 4569800
    [No Abstract] [Full Text] [Related]

  • 17. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS, Kumar V, Bennett M.
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [Abstract] [Full Text] [Related]

  • 18. "Xenogeneic resistance" to rat bone marrow transplantation. III. Maturation age, and abrogation with cyclophosphamide, Corynebacterium parvum and fractionated irradiation.
    Rauchwerger JM, Gallagher MT, Monié HJ, Trentin JJ.
    Biomedicine; 1976 Jan; 24(1):20-5. PubMed ID: 773442
    [Abstract] [Full Text] [Related]

  • 19. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G, Anderson CG, Warner J.
    J Immunol; 1986 Jun 01; 136(11):3981-6. PubMed ID: 3517162
    [Abstract] [Full Text] [Related]

  • 20. Promotion of incidence of adenovirus type 12 transplantable tumors by carrageenan, a specific antimacrophage agent.
    Lotzová E, Richie ER.
    J Natl Cancer Inst; 1977 Apr 01; 58(4):1171-2. PubMed ID: 191626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.